Financial Support for Heart Failure
(FUND-HF Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to test whether financial support in the form of a one-time $500 stipend would improve medication adherence and quality of life in low-income, socially-needy patients with heart failure with reduced ejection fraction in the post-discharge setting. The main questions it aims to answer are: * Will financial support improve heart failure quality of life? * Will financial support improve medication adherence? Participants will complete surveys on quality of life, social stress, and spending habits at their baseline visit. Participants will be randomly assigned to receive $500 at their baseline visit or $0 at their baseline visit. At their one month visit, quality of life and medication adherence will be assessed. These results will be compared between groups. The group that received $0 at their baseline visit will be provided $500 at their one-month visit and return for a two-month visit. At that visit, quality of life and medication adherence will be assessed. These results will be compared to their one-month results. Researchers will compare the 1-month quality of life scores and medication adherence scores between the immediate financial support vs delayed financial support. Researchers will also compare 1-month vs 2-month quality of life and adherence data for participants who were randomized to the delayed financial support group.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. It focuses on financial support to improve medication adherence, so it's likely you will continue your current medications.
What data supports the effectiveness of the treatment Financial Support, Food Vouchers, Cash Assistance, Nutritional Support for heart failure?
Is financial support for heart failure safe for humans?
How does the treatment in the Financial Support for Heart Failure trial differ from other treatments for heart failure?
The treatment in this trial is unique because it focuses on providing financial support, such as food vouchers, to improve dietary habits and health outcomes, rather than using traditional medical interventions. This approach aims to address financial barriers to healthy eating, which can indirectly benefit heart health.68111213
Research Team
Ambarish Pandey, MD
Principal Investigator
UT Southwestern Medical Center
Eligibility Criteria
This trial is for adults over 18 with heart failure and reduced ejection fraction, living on a low income (below 130% of the Federal Poverty Limit), who have trouble paying bills and at least two other social challenges like food or housing issues. They must be English-speaking, from Dallas County, not in jail/prison, able to see well enough to participate, and willing to return for follow-up visits.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Visit
Participants complete surveys on quality of life, social stress, and spending habits. Random assignment to receive $500 or $0.
1-Month Follow-up
Quality of life and medication adherence are assessed. Participants in the delayed financial support group receive $500.
2-Month Follow-up
Quality of life and medication adherence are assessed for the delayed financial support group.
Follow-up
Participants are monitored for safety and effectiveness after the intervention period.
Treatment Details
Interventions
- Financial Support
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor